Why Cryo-Cell International, Inc.’s (CCEL) Stock Is Down 14.94%
As of Monday, March 03, Cryo-Cell International, Inc.’s CCEL share price has dipped by 14.94%, which has investors questioning if this is right time to buy.Tudor Pop
Stock Evaluator: Cryo-Cell International, Inc. (CCEL)
Cryo-Cell International, Inc. CCEL
$4.49
-0.19
-4.06%
October 22, 2026 4:00:00 PM
EST
Volume: 6,531
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
AMEX | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Providers & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. It is also involved in the manufacturing of PrepaCyte CB processing system units for processing umbilical cord blood stem cells. In addition, the company provides cold storage services to third-party pharmaceutical companies and medical institutions. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.
Commentary & Analysis
7 Undervalued Healthcare Facilities & Services Stocks for Monday, May 22
Discover the top 7 undervalued Healthcare Facilities & Services stocks for Monday, May 22 based on AAII’s Stock Grades.Jack Gilleland
5 Undervalued Healthcare Facilities & Services Stocks for Wednesday, April 19
Discover the top 5 undervalued Healthcare Facilities & Services stocks for Wednesday, April 19 based on AAII’s Stock Grades.Jenna Brashear
Is CRYO-CELL International, Inc. (CCEL) Stock a Good Investment?
Learn more about CRYO-CELL International, Inc.'s (CCEL) stock grades for Value, Momentum, Growth and Estimate Revisions and determine whether this Healthcare Facilities & Services stock meets your investment needs.Jenna Brashear
Financial Summary
| Share Statistics | CCEL | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $37.7 | $1,813.3 | 14% |
|
| Shares Out (Mil) | 8.1 | 80.1 | 19% |
|
| Institutional Ownership | 14.7% | 86.1% | 8% |
|
| Float (Mil) | 4.1 | 55.9 | 10% |
|
| Beta | 0.59 | 0.82 | 34% |
|
| Avg Daily Volume (000s) | 14 | 593 | 19% |
|
| Price Change (52-week) |
(0.8%) | 79.4% | 51% |
|
| Growth | CCEL | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 0.3% | 10.4% | 18% |
|
| Net Income (5yr) | (21.7%) | (0.5%) | 19% |
|
| EPS (5yr) | (21.7%) | 2.1% | 12 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (15.5%) | (17.4%) | 48% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 1 | 1 | 1 | |
| Current EPS | $0.050 | $0.110 | $0.020 | |
| Month Ago EPS | $0.050 | $0.110 | $0.020 | |
| # Rev Up | 0 | 0 | na | |
| # Rev Down | 1 | 1 | na | |
| Three Months Ago EPS | $0.050 | $0.110 | $0.020 | |
| Year/Year Chg | (68.4%) | (136.5%) | na | |
| Financials | CCEL | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $31 | $1,504 | 16% |
|
| Net Income (TTM) (Mil) | ($2) | $28 | 36% |
|
| EPS (TTM) | ($0.241) | $0.200 | 32% |
|
| Operating Cash Flow (TTM) (Mil) | $5 | $162 | 36% |
|
| Net Cash Flow (TTM) (Mil) | $1 | $2 | 46% |
|
| Long-Term Debt (Q1) (Mil) | $8 | $375 | 27% |
|
| Enterprise Value (Q1) (Mil) | $42 | $2,330 | 15% |
|
| Valuation | CCEL | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 3.00 | na |
|
| P/E | na | 27.3 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | CCEL | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 64.5% | 27.4% | 77% |
|
| Net Margin | (6.2%) | 1.3% | 24% |
|
| ROA | (3.1%) | 2.2% | 32% |
|
| ROE | 12.5% | 7.1% | 64% |
|
| Liabilities to Assets | 126.3% | 61.5% | 97% |
|
| F-Score | 4 | 5 | 33% |
|
Cryo-Cell International, Inc. did not pass any screens on 10/22/2026.
